New Magic Mushrooms Could Fix Depression, Addiction, Epilepsy, and More

Featured /

Via Observer.com In the late 1950s, Albert Hofmann, the Swiss chemist who “discovered” LSD mostly by accident, started experimenting with something even more powerful: magic mushrooms. Indigenous people in Mexico had been observed using mushrooms in religious rituals by western visitors several years earlier. One of the interlopers sent a sample to Hofmann, who became the first […]

New Magic Mushrooms Could Fix Depression, Addiction, Epilepsy, and More Read More »

Magic Mushrooms Are Expanding Minds and Advancing an Emerging Field of Science

Psilocybin News /

Via Discover Magazine Science on psychedelic fungi is thawing after decades of prohibition. Here’s what we know so far. They’ve been credited in part for the musical and artistic revolutions of the late 1960s. According to some scientific opinions, they have potentially inspired early creativity in humans and our ancient ancestors. Researchers have seen them

Magic Mushrooms Are Expanding Minds and Advancing an Emerging Field of Science Read More »

Some doctors, therapists get Health Canada permission to use magic mushrooms

Featured /

Via CBC The health professionals can use psilocybin themselves to begin to develop therapies Four months after it allowed a handful of palliative care patients to use psilocybin as a way to relieve end-of-life suffering, Health Canada has cleared the way for more than a dozen health professionals to use the psychedelic drug themselves to

Some doctors, therapists get Health Canada permission to use magic mushrooms Read More »

Global Psychedelic Therapeutics Market, 2020-2030

Market News /

Via Business Insider NEW YORK, Oct. 8, 2020 /PRNewswire/ — INTRODUCTIONDepression is one of the most common chronic neurological conditions in modern society. It is estimated that over 250 million people, across all age groups, suffer from some form of depression, worldwide. Moreover, this condition along with other mental health disorders are estimated to be responsible for

Global Psychedelic Therapeutics Market, 2020-2030 Read More »

Why Compass Pathways Is Soaring Today

Market News /

Via Motley Fool What happened Last Friday, U.K.-based Compass Pathways (NASDAQ: CMPS) became the first psychedelic medicine company to go public on a major U.S. exchange. The drugmaker’s shares promptly rose by an eye-catching 70.5% during their first day of trading on the Nasdaq stock exchange. Compass’ upward momentum, following this historic public debut, appears set to

Why Compass Pathways Is Soaring Today Read More »

Psyched: Compass Joins Nasdaq, Field Trip Goes Public, MindMed Begins Trials, ATAI Launches MDMA Subsidiary

Market News /

Via benzinga Compass Pathways Files for an IPO at NASDAQ UK-based Compass Pathways wants to become the first psychedelics company to list on a major U.S. stock exchange. The psilocybin research company intends to make its initial public offering (IPO) through NASDAQ under the ticker symbol CMPS. With the filing, Compass expects to raise about $100 million that will

Psyched: Compass Joins Nasdaq, Field Trip Goes Public, MindMed Begins Trials, ATAI Launches MDMA Subsidiary Read More »

Magic Mushroom Drug-Backer Compass Pathways Files for U.S. IPO

Market News /

Via Bloomberg Compass Pathways Plc., a U.K. startup backed by tech billionaire Peter Thiel and lead investor Christian Angermayer, has filed to go public about four years after it was founded to explore the use of a psychedelic compound found in so-called magic mushrooms for treating depression. The London-based firm filed to raise $100 million,

Magic Mushroom Drug-Backer Compass Pathways Files for U.S. IPO Read More »